Ten-year prognosis of Puumala hantavirus-induced acute interstitial nephritis

Kidney International

Volumn 69, Issue 11, 2006, Pages 2043-2048

  Miettinen, M H ^a   Makela S M ^b,d   Ala Houhala, I O ^b,d   Huhtala, H S A ^c   Koobi T ^d   Vaheri, A I ^e   Pasternack, A I ^b   Porsti I H ^b,d   Mustonen, J T ^b,d  

^a JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Acute interstitial nephritis; Hemorrhagic fever of renal syndrome; Nephropathia epidemica; Prognosis; Puumala hantavirus

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ACUTE DISEASE; ADULT; AGED; AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ELECTROCARDIOGRAM; FEMALE; GLOMERULUS FILTRATION RATE; HANTAVIRUS; HUMAN; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; PUUMALA VIRUS; URINARY EXCRETION; VIRUS HEMORRHAGIC FEVER;

EID: 33745239219     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000334     Document Type: Article

References (29)

1. Vapalahti O, Mustonen J, Lundkvist Å et al. Hantavirus infections in Europe. Lancet Infect Dis 2003; 3: 653-661.
2. Brummer-Korvenkontio M, Vapalahti O, Henttonen H et al. Epidemiological study of nephropathia epidemica in Finland 1989-1996. Scand J Infect Dis 1999; 31: 427-435.
3. Saha H, Mustonen J, Helin H, Pasternack A. Limited value of the fractional excretion of sodium test in the diagnosis of acute renal failure. Nephrol Dial Transplant 1987; 2: 79-82.
4. Lähdevirta J. Nephropathia epidemica in Finland. A clinical, histological and epidemiological study. Ann Clin Res 1971; 3(Suppl 8): S1-S154.
5. Settergren B. Clinical aspects of nephropathia epidemica (Puumala virus infection) in Europe: a review. Scand J Infect Dis 2000; 32: 125-132.
6. Mustonen J, Brummer-Korvenkontio M, Hedman K et al. Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis 1994; 26: 7-13.
7. Mustonen J, Helin H, Pietilä K et al. Renal biopsy findings and clinicopathologic correlations in nephropathia epidemica. Clin Nephrol 1994; 41: 121-126.
8. Niklasson B, Hellsten G, LeDuc J. Hemorrhagic fever with renal syndrome: a study of sequelae following nephropathia epidemica. Arch Virol 1994; 137: 241-247.
9. Mäkelä S, Ala-Houhala I, Mustonen J et al. Renal function and blood pressure five years after Puumala virus-induced nephropathy. Kidney Int 2000; 58: 1711-1718.
10. Glass GE, Watson AJ, LeDuc JW et al. Infection with a rat borne hantavirus in US residents is consistently associated with hypertensive renal disease. J Infect Dis 1993; 167: 614-620.
11. Staessen JA, O'Brien ET, Amery AK et al. Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database. J Hypertens 1994; 12(Suppl 7): S1-S12.
12. Lähdevirta J, Collan Y, Jokinen EJ, Hiltunen R. Renal sequelae to nephropathia epidemica. Acta Pathol Microbiol Scand Sect A 1978; 86: 265-271.
13. Rubini MME, Jablon S, McDowell ME. Renal residuals of acute epidemic hemorrhagic fever. Arch Intern Med 1960; 106: 378-387.
14. Kleinknecht D, Rollin PE. Hypertension after hemorrhagic fever with renal syndrome. Nephron 1992; 61: 121.
15. Cowley Jr AW, Roman RJ. The role of the kidney in hypertension. JAMA 1996; 275: 1581-1589.
16. Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med 2002; 346: 913-923.
17. Gajdusek DC. Muroid virus nephropathies and muroid viruses of the Hantaan virus group. Scand J Infect Dis 1982; 36(Suppl): S96-S108.
18. Collan Y, Mihatsch MJ, Lähdevirta J et al. Nephropathia epidemica: mild variant of haemorrhagic fever with renal syndrome. Kidney Int 1991; 40(Suppl 35): S62-S71.
19. Temonen M, Mustonen J, Helin H et al. Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol 1996; 78: 47-55.
20. Yanagihara R, Silverman DJ. Experimental infection of human vascular endothelial cells by pathogenic and non-pathogenic hantaviruses. Arch Virol 1990; 111: 281-286.
21. Pensiero MN, Sharefkin JB, Dieffenbach CW, Hay J. Hantaan virus infection of human endothelial cells. J Virol 1992; 66: 5929-5936.
22. Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987; 31: 673-689.
23. Wirta OR, Pasternack AI. Glomerular filtration rate and kidney size in type 2 (non-insulin-dependent) diabetes mellitus. Clin Nephrol 1995; 44: 1-7.
24. Wong H, Vivian L, Weiler G, Filler G. Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease. Am J Kidney Dis 2004; 43: 624-628.
25. Schmieder RE, Veelken R, Schobel H et al. Glomerular hyperfiltration during sympathetic nervous system activation in early essential hypertension. J Am Soc Nephrol 1997; 8: 893-900.
26. Elisaf M, Korakis H, Siamopoulos KC. Chronic renal dysfunction in hemorrhagic fever with renal syndrome patients. Renal Failure 1993; 15: 623-627.
27. Ala-Houhala I, Koskinen M, Ahola T et al. Increased glomerular permeability in patients with nephropathia epidemica caused by Puumala hantavirus. Nephrol Dial Transplant 2002; 17: 246-252.
28. Vapalahti O, Lundkvist Å, Kallio-Kokko H et al. Antigenic properties and diagnostic potential of Puumala virus nucleocapsid protein expressed in insect cells. J Clin Microbiol 1996; 34: 119-125.
29. Guidelines Sub-Committee. World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 151-183.